Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Celecoxib does not protect against fibrosis and inflammation in a carbon tetrachloride-induced model of liver injury

Todd R Harris, Sean Kodani, Amy A Rand, Jun Yang, Denise M Imai, Sung Hee Hwang and Bruce D. Hammock
Molecular Pharmacology May 29, 2018, mol.118.111831; DOI: https://doi.org/10.1124/mol.118.111831
Todd R Harris
University of California, Davis;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sean Kodani
University of California, Davis;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy A Rand
University of California, Davis;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Yang
University of California, Davis;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denise M Imai
University of California, Davis;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sung Hee Hwang
University of California, Davis;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce D. Hammock
University of California - Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Additional Files

  • Data Supplement

    • Supplemental Data -

      Supplemental Table 1 - Histopathology scoring system

      Supplemental Table 2-  Retention time, selected reaction monitoring (SRM) and internal standard information used to quantify analytes from arachidonic acid cascade

      Supplemental Table 3 - Raw data for figures (units described in respective figure legends)

      Supplemental Table 4 - Hepatic oxylipin levels for analytes in the arachidonic acid cascade

      Supplemental Figure 1 - Arachidonic acid is metabolized by three major classes of enzymes to produce bioactive oxylipids, including the EETs, which are further metabolized by sEH

      Supplemental Figure 2 - All mice gained weight throughout the course of the experiment

      Supplemental Figure 3 - Celecoxib and CCl4 modulate metabolites in the P450 branch of the arachidonic acid cascade

Next
Back to top

In this issue

Molecular Pharmacology: 97 (1)
Molecular Pharmacology
Vol. 97, Issue 1
1 Jan 2020
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Celecoxib does not protect against fibrosis and inflammation in a carbon tetrachloride-induced model of liver injury
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
Citation Tools
Research ArticleArticle

Celecoxib does not protect against fibrosis and inflammation in a carbon tetrachloride-induced model of liver injury

Todd R Harris, Sean Kodani, Amy A Rand, Jun Yang, Denise M Imai, Sung Hee Hwang and Bruce D. Hammock
Molecular Pharmacology May 29, 2018, mol.118.111831; DOI: https://doi.org/10.1124/mol.118.111831

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Celecoxib does not protect against fibrosis and inflammation in a carbon tetrachloride-induced model of liver injury

Todd R Harris, Sean Kodani, Amy A Rand, Jun Yang, Denise M Imai, Sung Hee Hwang and Bruce D. Hammock
Molecular Pharmacology May 29, 2018, mol.118.111831; DOI: https://doi.org/10.1124/mol.118.111831
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Operational Models for Receptors with Multiple Agonist Sites
  • BODIPY-cyclopamine Binding to Nluc-SMO
  • Characterization and optimization of the novel TRPM2 antagonist tatM2NX
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2019 by the American Society for Pharmacology and Experimental Therapeutics